← FDA Drug Approvals (Drugs@FDA)

MILPREM-200

NDA · New Drug Application · Sponsor: MEDPOINTE PHARM HLC

Drug application

FDA Application #

NDA011045

Application type

New Drug Application

Brand name

MILPREM-200

Generic name

Estrogens, Conjugated

Active ingredients

ESTROGENS, CONJUGATED; MEPROBAMATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

MEDPOINTE PHARM HLC

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown